Jason was part of the founding team at Unchained Labs in January 2015, building a $75M+, profitable business before selling it to The Carlyle Group in May 2021 for $435M (>7x trailing revenues). He led the finance, accounting, and all administrative functions, and was on the front line of fundraising, six acquisitions, and integration of those businesses. At Unchained, Jason raised $85M+ of venture capital and $50M+ of commercial and venture debt. He also established and led the manufacturing and customer care functions when the company was founded in 2015, as its COO/CFO. Prior to joining Unchained Labs, Jason was the CFO and VP of Operations at ProteinSimple, helping raise $60M as they acquired four businesses and built a $60M+, profitable life sciences tools company over a six-year period. ProteinSimple was ultimately sold to Bio-Techne in July 2014 for $300M. Prior to ProteinSimple, he was the VP, Finance at Nektar Therapeutics. Earlier in his career, Jason spent nearly seven years in various senior financial leadership roles at Molecular Devices, responsible for the worldwide accounting, finance, and treasury functions, and played a key role in the execution and integration of its corporate development activities. He began his career with Ernst & Young, based in San Francisco, California, and is a CPA (inactive). He holds a B.S. in Business Administration from Cal Poly San Luis Obispo, where he was also a pitcher for Cal Poly’s D1 baseball program. Jason and his wife Erin have two kids, and when not coaching little league baseball, you can find him on the golf course or cheering on the SF Giants and 49ers, as well as supporting the Cal Poly Baseball program.